These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8882894)

  • 1. DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata.
    Cormican MG; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):83-7. PubMed ID: 8882894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Zhang J; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):63-7. PubMed ID: 9147006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.
    Pfaller MA; Messer SA; Hollis RJ
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):127-33. PubMed ID: 7874879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
    Pfaller MA; Messer SA; Hollis RJ
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):9-14. PubMed ID: 7789100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
    Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
    Pfaller MA; Messer SA; Houston A; Rangel-Frausto MS; Wiblin T; Blumberg HM; Edwards JE; Jarvis W; Martin MA; Neu HC; Saiman L; Patterson JE; Dibb JC; Roldan CM; Rinaldi MG; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 May; 31(1):289-96. PubMed ID: 9597389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
    Barchiesi F; Falconi Di Francesco L; Arzeni D; Caselli F; Gallo D; Scalise G
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):184-7. PubMed ID: 10357051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
    Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular investigation of two consecutive nosocomial clusters of Candida tropicalis candiduria using pulsed-field gel electrophoresis.
    Rho J; Shin JH; Song JW; Park MR; Kee SJ; Jang SJ; Park YK; Suh SP; Ryang DW
    J Microbiol; 2004 Jun; 42(2):80-6. PubMed ID: 15357299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotype and genotype analysis of Torulopsis glabrata isolated from nosocomial infections].
    Eloy O; Lallali A; Pina P; Allouch PY; Ghnassia JC
    Ann Biol Clin (Paris); 1997; 55(4):323-6. PubMed ID: 9309231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.
    Zerva L; Hollis RJ; Pfaller MA
    J Clin Microbiol; 1996 Dec; 34(12):3031-4. PubMed ID: 8940443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
    Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M; Scaltrito MM; Morace G;
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.